Department of Internal Medicine, Albany Medical Center, 43 New Scotland Avenue, Albany, New York, 12208, United States of America.
Department of Internal Medicine, Albany Medical Center, 43 New Scotland Avenue, Albany, New York, 12208, United States of America.
Heart Lung. 2023 Jan-Feb;57:19-24. doi: 10.1016/j.hrtlng.2022.08.007. Epub 2022 Aug 11.
The impact of the right ventricular (RV) structure and function on the in-hospital outcomes in patients with COVID-19 infection has not been rigorously investigated.
The main aim of our study was to investigate in-hospital outcomes including mortality, ICU admission, mechanical ventilation, pressor support, associated with RV dilatation, and RV systolic dysfunction in COVID-19 patients without a history of pulmonary hypertension.
It was a single academic tertiary center, retrospective cohort study of 997 PCR-confirmed COVID-19 patients. One hundred ninty-four of those patients did not have a history of pulmonary hypertension and underwent transthoracic echocardiography at the request of the treating physicians for clinical indications. Clinical endpoints which included mortality, ICU admission, need for mechanical ventilation or pressor support were abstracted from the electronic charts.
Patients' mean age was 68+/-16 years old and 42% of the study population were females. COPD was reported in 13% of the study population, whereas asthma was 10%, and CAD was 25%. The mean BMI was 29.8+/-9.5 kg/m2. Overall mortality was 27%, 46% in ICU patients, and 9% in the rest of the cohort. There were no significant differences in co-morbidities between expired patients and the survivors. A total of 19% of patients had evidence of RV dilatation and 17% manifested decreased RV systolic function. RV dilatation or decreased RV systolic function were noted in 24% of the total study population. RV dilatation was significantly more common in expired patients (15% vs 29%, p = 0.026) and was associated with increased mortality in patients treated in the ICU (HR 2.966, 95%CI 1.067-8.243, p = 0.037), who did not need require positive pressure ventilation, IV pressor support or acute hemodialysis.
In hospitalized COVID-19 patients without a history of pulmonary hypertension, RV dilatation is associated with a 2-fold increase in inpatient mortality and a 3-fold increase in ICU mortality.
右心室(RV)结构和功能对 COVID-19 感染患者住院期间结局的影响尚未得到严格研究。
本研究的主要目的是研究住院期间的结局,包括死亡率、入住 ICU、机械通气、升压支持,与 COVID-19 患者中 RV 扩张和 RV 收缩功能障碍相关,这些患者没有肺动脉高压病史。
这是一项单中心、回顾性队列研究,纳入了 997 例经 PCR 确诊的 COVID-19 患者。其中 194 例患者没有肺动脉高压病史,并应治疗医生的临床指征要求进行了经胸超声心动图检查。从电子病历中提取死亡率、入住 ICU、需要机械通气或升压支持等临床终点。
患者的平均年龄为 68+/-16 岁,42%为女性。研究人群中 COPD 占 13%,哮喘占 10%,CAD 占 25%。平均 BMI 为 29.8+/-9.5 kg/m2。总体死亡率为 27%,ICU 患者为 46%,其余患者为 9%。死亡患者和幸存者的合并症无显著差异。共有 19%的患者有 RV 扩张的证据,17%的患者表现出 RV 收缩功能下降。RV 扩张或 RV 收缩功能下降见于 24%的总研究人群。死亡患者的 RV 扩张更为常见(15% vs 29%,p=0.026),与 ICU 治疗患者的死亡率增加相关(HR 2.966,95%CI 1.067-8.243,p=0.037),这些患者不需要正压通气、静脉升压支持或急性血液透析。
在没有肺动脉高压病史的住院 COVID-19 患者中,RV 扩张与住院死亡率增加 2 倍和 ICU 死亡率增加 3 倍相关。